Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts

被引:85
作者
Peterson, Luke F. [1 ]
Boyapati, Anita [1 ]
Ahn, Eun-Young [1 ]
Biggs, Joseph R. [1 ]
Okumura, Akiko Joo [1 ]
Lo, Miao-Chia [1 ]
Yan, Ming [1 ]
Zhang, Dong-Er [1 ]
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
关键词
D O I
10.1182/blood-2006-11-019265
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nonrandom and somatically acquired chromosomal translocations can be identified in nearly 50% of human acute myeloid leukemias. One common chromosornal translocation in this disease is the 8q22;21q22 translocation. It involves the AML1 (RUNX1) gene on chromosome 21 and the ETO (MTG8, RUNX1T1) gene on chromosome 8 generating the AML1-ET0 fusion proteins. In this review, we survey recent advances made involving secondary mutational events and alternative t(8;21) transcripts in relation to understanding AML1-ETO leukemogenesis.
引用
收藏
页码:799 / 805
页数:7
相关论文
共 105 条
[51]   The Leukemia-associated ETO homologues are differently expressed during hematopoietic differentiation [J].
Lindberg, SR ;
Olsson, A ;
Persson, AM ;
Olsson, I .
EXPERIMENTAL HEMATOLOGY, 2005, 33 (02) :189-198
[52]   The tetramer structure of the Nervy homology two domain, NHR2, is critical for AM1/ETO's activity [J].
Liu, YZ ;
Cheney, MD ;
Gaudet, JJ ;
Chruszcz, M ;
Lukasik, SM ;
Sugiyama, D ;
Lary, J ;
Cole, J ;
Dauter, Z ;
Minor, W ;
Speck, NA ;
Bushweller, JH .
CANCER CELL, 2006, 9 (04) :249-260
[53]  
Lu FM, 2003, CANCER RES, V63, P7056
[54]   AGE-RELATED AND GENDER-RELATED HETEROGENEITY OF CANCER CHROMOSOME-ABERRATIONS [J].
MERTENS, F ;
JOHANSSON, B ;
MITELMAN, F .
CANCER GENETICS AND CYTOGENETICS, 1993, 70 (01) :6-11
[55]   AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation [J].
Miyamoto, T ;
Weissman, IL ;
Akashi, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) :7521-7526
[56]   Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia [J].
Miyamoto, T ;
Nagafuji, K ;
Akashi, K ;
Harada, M ;
Kyo, T ;
Akashi, T ;
Takenaka, K ;
Mizuno, S ;
Gondo, H ;
Okamura, T ;
Dohy, H ;
Niho, Y .
BLOOD, 1996, 87 (11) :4789-4796
[57]   T(8-21) BREAKPOINTS ON CHROMOSOME-21 IN ACUTE MYELOID-LEUKEMIA ARE CLUSTERED WITHIN A LIMITED REGION OF A SINGLE GENE, AML1 [J].
MIYOSHI, H ;
SHIMIZU, K ;
KOZU, T ;
MASEKI, N ;
KANEKO, Y ;
OHKI, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10431-10434
[58]   THE T(8-21) TRANSLOCATION IN ACUTE MYELOID-LEUKEMIA RESULTS IN PRODUCTION OF AN AML1-MTG8 FUSION TRANSCRIPT [J].
MIYOSHI, H ;
KOZU, T ;
SHIMIZU, K ;
ENOMOTO, K ;
MASEKI, N ;
KANEKO, Y ;
KAMADA, N ;
OHKI, M .
EMBO JOURNAL, 1993, 12 (07) :2715-2721
[59]   Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22) [J].
Nanri, T ;
Matsuno, N ;
Kawakita, T ;
Suzushima, H ;
Kawano, F ;
Mitsuya, H ;
Asou, N .
LEUKEMIA, 2005, 19 (08) :1361-1366
[60]   AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1. [J].
Nishida, S ;
Hosen, N ;
Shirakata, T ;
Kanato, K ;
Yanagihara, M ;
Nakatsuka, S ;
Hoshida, Y ;
Nakazawa, T ;
Harada, Y ;
Tatsumi, N ;
Tsuboi, A ;
Kawakami, M ;
Oka, Y ;
Oji, Y ;
Aozasa, K ;
Kawase, I ;
Sugiyama, H .
BLOOD, 2006, 107 (08) :3303-3312